Patents by Inventor Michael Frodsham

Michael Frodsham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOTREXATE FORMULATION
    Publication number: 20240024327
    Abstract: A liquid pharmaceutical composition comprises methotrexate free acid and a buffer, wherein the pH of the composition is in the range of 6.5 to 8.2. Processes for preparation of the liquid pharmaceutical composition are also described. The liquid pharmaceutical composition is useful in therapy.
    Type: Application
    Filed: September 28, 2023
    Publication date: January 25, 2024
    Inventors: Michael FRODSHAM, Julie-Ann PENTON
  • Methotrexate formulation
    Patent number: 11771701
    Abstract: A liquid pharmaceutical composition comprises methotrexate free acid and a buffer, wherein the pH of the composition is in the range of 6.5 to 8.2. Processes for preparation of the liquid pharmaceutical composition are also described. The liquid pharmaceutical composition is useful in therapy.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: October 3, 2023
    Assignee: Therakind Ltd.
    Inventors: Michael Frodsham, Julie-Ann Penton
  • METHOTREXATE FORMULATION
    Publication number: 20210386746
    Abstract: A liquid pharmaceutical composition comprises methotrexate free acid and a buffer, wherein the pH of the composition is in the range of 6.5 to 8.2. Processes for preparation of the liquid pharmaceutical composition are also described. The liquid pharmaceutical composition is useful in therapy.
    Type: Application
    Filed: August 26, 2021
    Publication date: December 16, 2021
    Inventors: Michael Frodsham, Julie-Ann Penton
  • Methotrexate formulation
    Patent number: 11129833
    Abstract: A liquid pharmaceutical composition comprises methotrexate free acid and a buffer, wherein the pH of the composition is in the range of 6.5 to 8.2. Processes for preparation of the liquid pharmaceutical composition are also described. The liquid pharmaceutical composition is useful in therapy.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: September 28, 2021
    Assignee: Therakind Ltd.
    Inventors: Michael Frodsham, Julie-Ann Penton
  • METHOTREXATE FORMULATION
    Publication number: 20170312281
    Abstract: A liquid pharmaceutical composition comprises methotrexate free acid and a buffer, wherein the pH of the composition is in the range of 6.5 to 8.2. Processes for preparation of the liquid pharmaceutical composition are also described. The liquid pharmaceutical composition is useful in therapy.
    Type: Application
    Filed: October 28, 2015
    Publication date: November 2, 2017
    Applicant: Therakind Ltd.
    Inventors: Michael FRODSHAM, Julie-Ann PENTON
  • Use of bethanechol for treatment of Xerostomia
    Patent number: 9492546
    Abstract: A formulation for topical administration, comprises bethanechol and a penetration enhancer. The formulation is preferably used by being maintained in the buccal cavity for a period of time prior to being swallowed.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: November 15, 2016
    Assignee: Acacia Pharma Limited
    Inventors: Ian Walker, Michael Frodsham
  • Use of Bethanechol for Treatment of Xerostomia
    Publication number: 20140187629
    Abstract: A formulation for topical administration, comprises bethanechol and a penetration enhancer. The formulation is preferably used by being maintained in the buccal cavity for a period of time prior to being swallowed.
    Type: Application
    Filed: May 4, 2012
    Publication date: July 3, 2014
    Inventors: Ian Walker, Michael Frodsham